Overall, our data suggest that the TTNmv creates an EP substrate for AF by modulating IKs activity, in part by increasing the interaction between the KCNQ1-KCNE1 complex and FHL2 (Figure 5E). The gene discussed is KCNQ1; the disease is atrial fibrillation.